May 19, 2025
TOPLINE: Patients with axial spondyloarthritis (axSpA) and moderate to severe depressive symptoms were less likely to achieve low disease activity (LDA) and inactive disease following the […]
May 19, 2025
TOPLINE: Zimlovisertib plus tofacitinib showed greater efficacy than tofacitinib alone in reducing Disease Activity Score in 28 joints using C-reactive protein (DAS28-CRP) in patients with rheumatoid […]
May 16, 2025
MANCHESTER, England — The risks for infection are broadly similar regardless of the biologic or targeted synthetic disease-modifying drug used to treat inflammatory arthritis, but different […]
May 15, 2025
INCHEON, South Korea — Young veterans who have lost lower limbs in combat are at particularly high risk for developing hip osteoarthritis, but even uninjured veterans […]
May 14, 2025
TORONTO — After almost 10 years, the much-anticipated revision of the current classification criteria for the diagnosis of axial spondyloarthritis (axSpA) is ready for prime time. […]
May 14, 2025
TOPLINE: In patients with systemic lupus erythematosus (SLE) who had been in remission for at least 1 year, immunosuppressant withdrawal was noninferior to glucocorticoid withdrawal, with […]
May 13, 2025
MANCHESTER, England — A soon-to-be-released guidance from the British Society for Rheumatology on the management of antineutrophil cytoplasmic antibody (ANCA)–associated vasculitis (AAV) emphasizes not only the […]
May 12, 2025
TOPLINE: Although remission rates of patients with early rheumatoid arthritis (RA) remained stable between 2018 and 2024 in England and Wales, regional differences were noted. Factors […]
May 12, 2025
TOPLINE: In a cohort of 2000 patients with systemic sclerosis (SSc), 20% were found to have multimorbidity, primarily driven by cardiovascular disease and other important cardiovascular […]